Jump to:
Trellus Health PLC Fundamentals
| Company Name | Trellus Health PLC | Last Updated | 2024-08-23 |
|---|
| Industry | Health Information Services | Sector | Healthcare |
|---|
| Shares in Issue | 161.508 m | Market Cap | £1.94 m |
|---|
| PE Ratio | 2.61 | Dividend per Share | 0 |
|---|
| Dividend Yield | 0 | Dividend Cover | 0 |
|---|
| EPS | -$0.04 | EPS Growth (%) | 0 |
|---|
| PEG | 0 | DPS Growth (%) | 0 |
|---|
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
|---|
| Asset Equity Ratio | 1.0403 | Cash Equity Ratio | 0.6239 |
|---|
| Quick Ratio | 15.4949 | Current Ratio | 15.69 |
|---|
| Price To Book Value | 0.1302 | ROCE | 0 |
|---|
Trellus Health PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Trellus Health PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|
| Tangible Assets | $35,000.00 | $58,000.00 | $82,000.00 |
| Intangible Assets | $7.92 m | $6.49 m | $4.28 m |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | $7.96 m | $6.55 m | $4.36 m |
| Stocks | 0 | 0 | 0 |
| Debtors | $13,000.00 | 0 | $123,000.00 |
| Cash & Equivalents | $12.17 m | $19.09 m | $31.98 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | $20.29 m | $25.91 m | $36.80 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|
| Creditors within 1 year | $786,000.00 | $822,000.00 | $1.52 m |
| Creditors after 1 year | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $786,000.00 | $822,000.00 | $1.52 m |
| Net assets | $19.50 m | $25.09 m | $35.27 m |
| Equity | 2023 | 2022 | 2021 |
|---|
| Called up share capital | $137,000.00 | $137,000.00 | $137,000.00 |
| Share Premium | $43.39 m | $43.39 m | $43.39 m |
| Profit / Loss | -$6.34 m | -$8.81 m | -$5.90 m |
| Other Equity | $19.50 m | $25.09 m | $35.27 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $19.50 m | $25.09 m | $35.27 m |
| Ratios | 2023 | 2022 | 2021 |
|---|
| Debt Ratio | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 |
| Assets / Equity | 1.0403 | 1.0403 | 1.0403 |
| Cash / Equity | 0.6239 | 0.6239 | 0.6239 |
| EPS | -$0.04 | -$0.05 | $-0.00 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|
| Cash from operating activities | -$5.27 m | -$8.62 m | -$4.77 m |
| Cashflow before financing | -$5.27 m | -$8.62 m | $33.74 m |
| Increase in Cash | -$7.63 m | -$11.53 m | $30.02 m |
| Income | 2023 | 2022 | 2021 |
|---|
| Turnover | $19,000.00 | $18,000.00 | $25,000.00 |
| Cost of sales | 0 | 0 | 0 |
| Gross Profit | $19,000.00 | $18,000.00 | $25,000.00 |
| Operating Profit | -$6.80 m | -$8.81 m | -$5.90 m |
| Pre-Tax profit | -$6.34 m | -$8.81 m | -$5.90 m |
Trellus Health PLC Company Background
| Sector | Healthcare |
|---|
| Activities | Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions. |
|---|
| Latest Interim Date | 28 Sep 2023 |
|---|
| Latest Fiscal Year End Date | 23 Apr 2024 |
|---|
Trellus Health PLC Directors
| Appointed | Name | Position |
|---|
| 2024-02-28 | Mr. Christopher Harwood Bernard Mills | Non-Executive Director |
| 2023-02-06 | Mr. Julian Huw Baines MBE | Non-Executive Director,Chairman |
| 2024-05-21 | Mr. David Michael Salter | Non-Executive Director |
| 2022-07-19 | Ms. Monique Fayad | Executive Director,Chief Executive Officer |
| 2024-05-21 | Dr. Marla Dubinsky | Executive Director,Chief Executive Officer |
| 2024-06-14 | Dr. Daniel Mahony | Non-Executive Director,Chairman |
| 2024-05-21 | Ms. Traci Allison Entel | Non-Executive Director |
Trellus Health PLC Contact Details
Trellus Health PLC Advisors
